http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0128437-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dbdfc93841b3d731fbab7ea48b412a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-06 |
| filingDate | 1984-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a83c0edba43a9161ecc75068bef7125 |
| publicationDate | 1984-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0128437-A2 |
| titleOfInvention | Nortropine derivative, process for its preparation and its use |
| abstract | The invention relates to the compound N-β-fluoroethylnortropine, which is suitable as an intermediate for the production of valuable pharmaceuticals (e.g. quaternary N-β-fluoroethylnortropine ester with spasmolytic and bronchospasmolytic activity) or as a pharmaceutical active substance.n n n This compound can be prepared, for example, by N-alkylation of nortropine with 2-bromofluoroethane.n n n Their acylation with benzilimidazolide leads to the benzilic acid N-β-fluoroethylnortropine ester, which in turn can be reacted with quaternizing agents to give the pharmacologically interesting quaternary benzilic acid N-β-fluoroethylnortropine esters. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2630439-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9216528-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8910373-A1 |
| priorityDate | 1983-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.